"Endostatins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Angiostatic proteins that are formed from proteolytic cleavage of COLLAGEN TYPE XVIII.
| Descriptor ID |
D043169
|
| MeSH Number(s) |
D12.644.276.100.450.750 D12.776.467.100.450.750 D12.776.860.300.250.400.537.500 D23.529.100.450.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Endostatins".
Below are MeSH descriptors whose meaning is more specific than "Endostatins".
This graph shows the total number of publications written about "Endostatins" by people in this website by year, and whether "Endostatins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Endostatins" by people in Profiles.
-
Poluzzi C, Iozzo RV, Schaefer L. Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers. Adv Drug Deliv Rev. 2016 Feb 01; 97:156-73.
-
Al Ahmad A, Lee B, Stack J, Parham C, Campbell J, Clarke D, Fertala A, Bix GJ. Endostatin binds nerve growth factor and thereby inhibits neurite outgrowth and neuronal migration in-vitro. Brain Res. 2010 Nov 11; 1360:28-39.
-
Mongiat M, Sweeney SM, San Antonio JD, Fu J, Iozzo RV. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J Biol Chem. 2003 Feb 07; 278(6):4238-49.